Abstract:Introduction Recent clinical and preclinical evidences suggested that neuroinflammation is a key factor which interacts with the neurobiological correlates of major depressive disorder, which are the (i) dysregulation of the hypothalamic-pituitary-adrenal axis, (ii) depletion of brain serotonin and (iii) alteration of neurogenesis in the dentate gyrus of the hippocampus. The gut bacterial has major impact on the brain development, behaviour and host immune system through the microbiota-gut-brain axis. Objectives The objective of the research is to establish the role inflammation induced by gut dysbiosis plays in behavioural changes of patients suffering from major depressive disorders. Methods Clinical data and preclinical experiments were used to elucidate the role gastrointestinal bacterial play in the development and functional physiology of the nervous system and because of the bidirectional communication between the enteric nervous system in the gut and the central nervous system, through the vagal plexus, blood circulation and endocrine system; it was discovered that the appropriate population of intestinal microbiota affect the immunological state of the brain. Results The intestinal microbiota has been able to maintain the attenuation and regulation of pro-inflammatory biomarkers in the brain and such had assisted in the healthy state of the brain; however, a disruption of gastrointestinal organisms in a condition called dysbiosis could result in breakdown of protective gastrointestinal mucosa barrier resulting in leaky gut and consequently, the permeability of the gut lining and migration of some bacteria, to the brain through the vagal networks and other channels. These pathophysiological cascades appear to be triggered or sustained and reinforced by chronic inflammatory condition involving increased circulating markers of inflammation, which are able to cross the blood brain barrier to activate the microglia. Conclusions Studies in depression suggest that inflammatory biomarkers such as C-reactive protein can be used to enrich samples for anti-inflammatory clinical trials for depression that target inflammation-related symptoms such as anhedonia and anxiety. Although, still at the developmental stages, imaging of neuroinflammation will help establish a target in the brain to further facilitate the testing of anti-inflammatory therapies for depression. Disclosure of Interest None Declared

Psychoneuroimmunology of depression and its relation to the gut-brain axis

Epigenetics in depression and gut-brain axis: A molecular crosstalk

Gut-brain axis: A matter of health and disease in neuropsychiatric disorders…!

The role of the gut-brain axis in depression: endocrine, neural, and immune pathways

Gut-brain axis: A matter of concern in neuropsychiatric disorders ...!

The Role of the Microbiome-Brain-Gut Axis in the Pathogenesis of Depressive Disorder

Mood and microbes: a comprehensive review of intestinal microbiota's impact on depression

Exploring the gut-brain Axis: Potential therapeutic impact of Psychobiotics on mental health

Brain–gut–microbiota axis in depression: A historical overview and future directions

The microbiota-gut-brain axis in pathogenesis of depression: a narrative review

The Power of Psychobiotics in Depression: A Modern Approach through the Microbiota–Gut–Brain Axis: A literature Review

Microbes, Immunity, and Behavior: Psychoneuroimmunology Meets the Microbiome

Gut-brain axis in depression: Crosstalk between neuroinflammation and gut microbiota

Intestinal Barrier, Immunity and Microbiome: Partners in the Depression Crime

A Reciprocal Link Between Gut Microbiota, Inflammation and Depression: A Place for Probiotics?

The microbiota-gut-brain axis in stress and depression

Mechanistic Insights into the Link between Gut Dysbiosis and Major Depression: An Extensive Review

Depressed gut? The microbiota-diet-inflammation trialogue in depression

The Microbiota–Gut–Brain Axis in Depression: The Potential Pathophysiological Mechanisms and Microbiota Combined Antidepression Effect

Gut Microorganisms, Neuroinflammation and Behavioral Changes

Gut microbiota–brain axis in depression: The role of neuroinflammation